These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25792217)

  • 1. Implementation of a cost-accounting model in a biobank: practical implications.
    Gonzalez-Sanchez MB; Lopez-Valeiras E; García-Montero AC
    Pathobiology; 2014; 81(5-6):286-297. PubMed ID: 25792217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustainability in Biobanking: Model of Biobank Graz.
    Sargsyan K; Macheiner T; Story P; Strahlhofer-Augsten M; Plattner K; Riegler S; Granitz G; Bayer M; Huppertz B
    Biopreserv Biobank; 2015 Dec; 13(6):410-20. PubMed ID: 26697910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population biobanking and international collaboration.
    Zawati MH; Knoppers B; Thorogood A
    Pathobiology; 2014; 81(5-6):276-285. PubMed ID: 25792216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Biobank Economic Modeling Tool (BEMT): Online Financial Planning to Facilitate Biobank Sustainability.
    Odeh H; Miranda L; Rao A; Vaught J; Greenman H; McLean J; Reed D; Memon S; Fombonne B; Guan P; Moore HM
    Biopreserv Biobank; 2015 Dec; 13(6):421-9. PubMed ID: 26697911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effective organization of an institutional human cancer biobank in a clinical setting: CRO-Biobank experience toward harmonization.
    Cervo S; De Paoli P; Perin T; Canzonieri V; Steffan A
    Int J Biol Markers; 2015 May; 30(2):e243-51. PubMed ID: 25744364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biobank Finances: A Socio-Economic Analysis and Review.
    Gee S; Oliver R; Corfield J; Georghiou L; Yuille M
    Biopreserv Biobank; 2015 Dec; 13(6):435-51. PubMed ID: 26697914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infrastructure and facilities for human biobanking in low- and middle-income countries: a situation analysis.
    Mendy M; Caboux E; Sylla BS; Dillner J; Chinquee J; Wild C;
    Pathobiology; 2014; 81(5-6):252-260. PubMed ID: 25792214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost model for biobanks.
    Gonzalez-Sanchez MB; Lopez-Valeiras E; Morente MM; Fernández Lago O
    Biopreserv Biobank; 2013 Oct; 11(5):272-7. PubMed ID: 24835258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The uniqueness of biobanks for neurological and psychiatric diseases: potentials and pitfalls.
    Ravid R
    Pathobiology; 2014; 81(5-6):237-244. PubMed ID: 25792212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Securing the sustainability of biobanks].
    Kirsten R; Hummel M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):390-5. PubMed ID: 26769112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward Global Biobank Integration by Implementation of the Minimum Information About BIobank Data Sharing (MIABIS 2.0 Core).
    Merino-Martinez R; Norlin L; van Enckevort D; Anton G; Schuffenhauer S; Silander K; Mook L; Holub P; Bild R; Swertz M; Litton JE
    Biopreserv Biobank; 2016 Aug; 14(4):298-306. PubMed ID: 26977825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The biological resources and molecule archives organization: turn a need into an opportunity for the Smart Specialization Strategy of the Lazio region.].
    Bravo E; Franchin T; Santoro F; Conti L; Carrara S; Marino M; Di Caro A; Cigliana G; Mandoj C; Baselice S; Daniele N; Giampaoli S; Quintarelli C; Salerno M; Zinno F; Russo G; Errico MC; Minghetti L; Ricciardi W; Napolitano M
    Recenti Prog Med; 2019 Feb; 110(2):68-74. PubMed ID: 30843531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to Make a Cost Model for the Birth Cohort Biobank in China.
    Wu M; Wu D; Hu C; Yan C
    Front Public Health; 2020; 8():24. PubMed ID: 32154203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next Chapter of the Taiwan Biobank: Sustainability and Perspectives.
    Lin JC; Chen LK; Hsiao WW; Fan CT; Ko ML
    Biopreserv Biobank; 2019 Apr; 17(2):189-197. PubMed ID: 30715914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Australian Biobank Certification Scheme: A Study of Economic Costs to Participating Biobanks.
    Ling R; Rush A; Carter C; Carpenter J; Watson PH; Byrne JA; Searles A
    Biopreserv Biobank; 2018 Feb; 16(1):53-58. PubMed ID: 29215912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biobanking trends, challenges, and opportunities.
    Mackenzie F
    Pathobiology; 2014; 81(5-6):245-251. PubMed ID: 25792213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legacy samples in Finnish biobanks: social and legal issues related to the transfer of old sample collections into biobanks.
    Salokannel M; Tarkkala H; Snell K
    Hum Genet; 2019 Dec; 138(11-12):1287-1299. PubMed ID: 31620872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biobank bootstrapping: is biobank sustainability possible through cost recovery?
    Albert M; Bartlett J; Johnston RN; Schacter B; Watson P
    Biopreserv Biobank; 2014 Dec; 12(6):374-80. PubMed ID: 25496148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conception and Implementation of an Austrian Biobank Directory Integration Framework.
    Hofer-Picout P; Pichler H; Eder J; Neururer SB; Müller H; Reihs R; Holub P; Insam T; Goebel G
    Biopreserv Biobank; 2017 Aug; 15(4):332-340. PubMed ID: 28380303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Practical use of biobank information management system (BIMS) for clinical-biological annotations in biobanks].
    Le Queau C; Ann Phillips W; Srinivasan A
    Med Sci (Paris); 2020 Mar; 36(3):285-288. PubMed ID: 32228852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.